Foghorn Therapeutics Inc. Common Stock

FHTXNASDAQ • USD
1.88 USD
↘ 0.20 (9.42%)🟢LIVE (AS OF 01:42 PM EST)
🟢Market: OPEN

Foghorn Therapeutics Inc. Common Stock (FHTX) trades at $1.88 per share. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a concerning Altman Z-Score in the distress zone, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of Nov 13, 2026.

Open?$2.05
High?$2.07
Low?$1.88
Prev. Close?$2.07
Volume?215.2K
Avg. Volume?733.6K
VWAP?$1.95
Rel. Volume?0.29x
Bid / Ask
Bid?$1.88 × 300
Ask?$1.89 × 1.1K
Spread?$0.01
Midpoint?$1.88
Valuation & Ratios
Market Cap?124.1M
Shares Out?60.0M
Float?33.8M
Float %?56.9%
P/E Ratio?13.18
P/B Ratio?-8.81
EPS?$0.16
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system. Its proprietary platform is designed to provide an integrated, mechanistic understanding of interactions within the chromatin regulatory system, supporting the identification and validation of potential therapeutic targets. The company's flagship program is FHD-909.
Employees
106
Market Cap
124.1M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2020-10-23
Address
500 TECHNOLOGY SQUARE
CAMBRIDGE, MA 02139
Phone: 617-586-3100
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
40
Z-Score?
0
Momentum?
85
Short Sent.?
74
Piotroski F-Score?4/9Mixed
Altman Z-Score?-2.66Distress
Confidence?46%Low
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?6.66%Elevated
Short Interest?2.3M
Days to Cover?3.9
Free Float33.8M
Avg Daily Volume577.1K
Settlement Date2026-10-30
Financial Health
Current Ratio?4.24Strong
Quick Ratio?4.24Strong
Cash Ratio?2.15Strong
Debt/Equity?-0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
Peers
100
S&P
87
13.2CHEAP▾
P/B?
S&P
97
-8.81CHEAP▾
P/S?
Peers
100
S&P
85
1.11CHEAP▾
P/FCF?
N/A▾
EV/EBITDA?
Peers
100
S&P
97
3.6CHEAP▾
EV/Sales?
Peers
100
S&P
97
0.39CHEAP▾
Returns & Efficiency
ROE?
S&P
3
-66.9%WEAK▾
ROA?
Peers
50
S&P
44
4.9%FAIR▾
Cash Flow & Enterprise
FCF?$-83681000
Enterprise Value?$43.8M
Fundamentals ratios updated end of day